(DKS) Dick’s Sporting Goods - Ratings and Ratios
Sporting Goods, Apparel, Footwear, Fitness Equipment, Outdoor Gear
Dividends
| Dividend Yield | 2.10% |
| Yield on Cost 5y | 9.92% |
| Yield CAGR 5y | 36.92% |
| Payout Consistency | 90.8% |
| Payout Ratio | 28.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 46.7% |
| Value at Risk 5%th | 62.6% |
| Relative Tail Risk | -18.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.35 |
| Alpha | -12.06 |
| CAGR/Max DD | 0.79 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.311 |
| Beta | 1.438 |
| Beta Downside | 1.249 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.73% |
| Mean DD | 10.70% |
| Median DD | 9.31% |
Description: DKS Dick’s Sporting Goods October 16, 2025
DICK Sports Goods, Inc. (NYSE: DKS) is a U.S.-based omni-channel retailer that sells a broad assortment of sporting-goods hardlines, apparel, footwear and accessories through its flagship stores, specialty concepts (e.g., Golf Galaxy, Moosejaw, Public Lands, Going Going Gone!), and digital channels, including a youth-sports mobile app called GameChanger.
In FY 2023 the company generated roughly $10.5 billion in revenue, with e-commerce sales accelerating ~12% year-over-year and same-store sales modestly positive (+2%) despite a soft discretionary environment. Key economic drivers include consumer confidence in discretionary spending, inflation-adjusted pricing pressure, and labor-cost trends that have compressed operating margins. The broader specialty-retail sector remains sensitive to macro-backdrop shifts, but DKS’s diversified brand portfolio and “House of Sport” experiential format help mitigate foot-traffic volatility.
For a deeper, data-driven look at DKS’s valuation assumptions and scenario outcomes, the ValueRay platform offers a concise analytical dashboard worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (1.02b TTM) > 0 and > 6% of Revenue (6% = 893.0m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -5.89pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.97% (prev 17.27%; Δ 0.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 1.17b > Net Income 1.02b (YES >=105%, WARN >=100%) |
| Net Debt (6.88b) to EBITDA (1.73b) ratio: 3.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.57 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (87.1m) change vs 12m ago 5.24% (target <= -2.0% for YES) |
| Gross Margin 35.33% (prev 35.74%; Δ -0.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 106.8% (prev 128.5%; Δ -21.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 21.86 (EBITDA TTM 1.73b / Interest Expense TTM 59.3m) >= 6 (WARN >= 3) |
Altman Z'' 3.51
| (A) 0.15 = (Total Current Assets 7.35b - Total Current Liabilities 4.68b) / Total Assets 17.43b |
| (B) 0.39 = Retained Earnings (Balance) 6.81b / Total Assets 17.43b |
| (C) 0.09 = EBIT TTM 1.30b / Avg Total Assets 13.94b |
| (D) 0.57 = Book Value of Equity 6.80b / Total Liabilities 11.91b |
| Total Rating: 3.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.54
| 1. Piotroski 4.0pt |
| 2. FCF Yield 0.55% |
| 3. FCF Margin 0.94% |
| 4. Debt/Equity 1.39 |
| 5. Debt/Ebitda 3.97 |
| 6. ROIC - WACC (= 11.87)% |
| 7. RoE 27.00% |
| 8. Rev. Trend 55.42% |
| 9. EPS Trend 20.38% |
What is the price of DKS shares?
Over the past week, the price has changed by +9.39%, over one month by +4.52%, over three months by +2.31% and over the past year by +9.23%.
Is DKS a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 15
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the DKS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 236.4 | 4.6% |
| Analysts Target Price | 236.4 | 4.6% |
| ValueRay Target Price | 274.8 | 21.6% |
DKS Fundamental Data Overview November 30, 2025
P/E Trailing = 16.8217
P/E Forward = 13.6799
P/S = 1.2447
P/B = 3.3693
P/EG = 2.6092
Beta = 1.191
Revenue TTM = 14.88b USD
EBIT TTM = 1.30b USD
EBITDA TTM = 1.73b USD
Long Term Debt = 1.48b USD (from longTermDebt, last fiscal year)
Short Term Debt = 995.5m USD (from shortTermDebt, last quarter)
Debt = 7.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.88b USD (from netDebt column, last quarter)
Enterprise Value = 25.40b USD (18.52b + Debt 7.70b - CCE 821.3m)
Interest Coverage Ratio = 21.86 (Ebit TTM 1.30b / Interest Expense TTM 59.3m)
FCF Yield = 0.55% (FCF TTM 140.4m / Enterprise Value 25.40b)
FCF Margin = 0.94% (FCF TTM 140.4m / Revenue TTM 14.88b)
Net Margin = 6.86% (Net Income TTM 1.02b / Revenue TTM 14.88b)
Gross Margin = 35.33% ((Revenue TTM 14.88b - Cost of Revenue TTM 9.62b) / Revenue TTM)
Gross Margin QoQ = 33.13% (prev 37.06%)
Tobins Q-Ratio = 1.46 (Enterprise Value 25.40b / Total Assets 17.43b)
Interest Expense / Debt = 0.24% (Interest Expense 18.3m / Debt 7.70b)
Taxrate = 27.96% (29.2m / 104.4m)
NOPAT = 933.4m (EBIT 1.30b * (1 - 27.96%))
Current Ratio = 1.57 (Total Current Assets 7.35b / Total Current Liabilities 4.68b)
Debt / Equity = 1.39 (Debt 7.70b / totalStockholderEquity, last quarter 5.52b)
Debt / EBITDA = 3.97 (Net Debt 6.88b / EBITDA 1.73b)
Debt / FCF = 48.99 (Net Debt 6.88b / FCF TTM 140.4m)
Total Stockholder Equity = 3.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.86% (Net Income 1.02b / Total Assets 17.43b)
RoE = 27.00% (Net Income TTM 1.02b / Total Stockholder Equity 3.78b)
RoCE = 24.61% (EBIT 1.30b / Capital Employed (Equity 3.78b + L.T.Debt 1.48b))
RoIC = 19.92% (NOPAT 933.4m / Invested Capital 4.69b)
WACC = 8.05% (E(18.52b)/V(26.22b) * Re(11.32%) + D(7.70b)/V(26.22b) * Rd(0.24%) * (1-Tc(0.28)))
Discount Rate = 11.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.66%
[DCF Debug] Terminal Value 59.42% ; FCFE base≈364.0m ; Y1≈258.9m ; Y5≈138.9m
Fair Price DCF = 25.61 (DCF Value 1.69b / Shares Outstanding 66.1m; 5y FCF grow -33.96% → 3.0% )
EPS Correlation: 20.38 | EPS CAGR: -6.94% | SUE: 0.40 | # QB: 0
Revenue Correlation: 55.42 | Revenue CAGR: 5.98% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.00 | Chg30d=-0.351 | Revisions Net=+0 | Analysts=17
EPS next Year (2027-01-31): EPS=14.90 | Chg30d=-0.568 | Revisions Net=+3 | Growth EPS=+15.0% | Growth Revenue=+28.2%
Additional Sources for DKS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle